Nevro (NYSE: NVRO) reported Q4 EPS of ($0.86), $0.01 better than the analyst estimate of ($0.87). Revenue for the quarter came in at $102.8 million versus the consensus estimate of $96.56 million.

Cash, cash equivalents and short-term investments totaled $362.0 million as of December 31, 2021, a decrease of $14.5 million from the third quarter of 2021.

For earnings history and earnings-related data on Nevro (NVRO) click here.